PDCD1LG2 and neoplasm: It is known that IFNγ itself promotes expression of PD-L1 and PD-L2 in tumor cells, as well as in stromal cells, including immune infiltrating cells, thereby suppressing the effector functions of tumor-specific T cells and NK cells via PD-1 [7, 46].